Cervical Intraepithelial Neoplasia (CIN) in Women Younger than 25 Years Old

被引:0
|
作者
Chavez Valdivia, Martha Maria [1 ]
Quinones Ceballos, Alfredo B. [2 ]
机构
[1] Hosp Pediat Paquito Gonzales Cueto, Cienfuegos 55100, Cienfuegos, Cuba
[2] Hosp Gen Univ Dr Gustavo Aldereguia Lima, Cienfuegos 55100, Cienfuegos, Cuba
来源
FINLAY | 2012年 / 2卷 / 01期
关键词
cervical intraepithelial neoplasia; canization; radiosurgery; middle aged; epidemiology Limits: Human; adult; female;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Although the incidence of preinvasive cervical lesions has always been greater in women from the third to the fourth decade of life, in recent years a considerable number of women under 25 years old affected by this type of injury in low or high grade have been detected. Objective: To describe the behaviour of cervical intraepithelial neoplasia diagnosed in women less than 25 years old and treated with radiosurgery. Methods: A retrospective and descriptive study of 67 patients under 25 years old, diagnosed with cervical intraepithelial neoplasia and treated by the method of radiosurgery in the General University Hospital of Cienfuegos. The following variables were analyzed: age, type and grade of Cervical Intraepithelial Neoplasia (CIN) and presence of Human papillomavirus (HPV). Results: The most affected group was that of women from 21 to 25 years old, where 70.4% of injuries appeared. 86, 56% of the lesions were of high grade. Lesions were associated with high frequency (88.05%) of condyloma and indirect histological evidence of cytotoxicity by tissue infestation of HPV. Conclusions: The presence of CIN in women under 25 years old has become a health issue in our current environment. This study can work as a basis to develop similar research in several places of the country, in order to provide evidence leading to global change.
引用
收藏
页码:45 / 49
页数:5
相关论文
共 50 条
  • [41] PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)
    OTRAKJI, C
    WU, W
    NAJJAR, R
    NADJI, M
    LABORATORY INVESTIGATION, 1992, 66 (01) : A67 - A67
  • [42] HPV vaccination after treatment of cervical intraepithelial neoplasia (CIN/HSIL)
    Dannecker, Christian
    GYNAKOLOGE, 2021, 54 (11): : 816 - 819
  • [43] CRYOSURGICAL TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN III) IN 102 PATIENTS
    VANLENT, M
    TRIMBOS, JB
    HEINTZ, APM
    VANHALL, EV
    GYNECOLOGIC ONCOLOGY, 1983, 16 (02) : 240 - 245
  • [44] MILD CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN-1) - A HISTOLOGICAL OVERDIAGNOSIS
    ALNAFUSSI, AI
    COLQUHOUN, MK
    HISTOPATHOLOGY, 1990, 17 (06) : 557 - 561
  • [45] FLUORESCENCE SPECTROSCOPY - A DIAGNOSTIC-TOOL FOR CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)
    RAMANUJAM, N
    MITCHELL, MF
    MAHADEVAN, A
    THOMSEN, S
    SILVA, E
    RICHARDSKORTUM, R
    GYNECOLOGIC ONCOLOGY, 1994, 52 (01) : 31 - 38
  • [46] INFLUENCE OF SEXUAL-ACTIVITY ON DEVELOPMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)
    HARAHAP, RE
    CANCER DETECTION AND PREVENTION, 1986, 9 (3-4): : 237 - 241
  • [47] THE CIN SAGA - THE BIOLOGICAL AND CLINICAL-SIGNIFICANCE OF CERVICAL INTRAEPITHELIAL NEOPLASIA
    CHANEN, W
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1990, 30 (01): : 18 - 23
  • [48] The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer
    James E. Barrett
    Karin Sundström
    Allison Jones
    Iona Evans
    Jiangrong Wang
    Chiara Herzog
    Joakim Dillner
    Martin Widschwendter
    Genome Medicine, 14
  • [49] The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer
    Barrett, James E.
    Sundstrom, Karin
    Jones, Allison
    Evans, Iona
    Wang, Jiangrong
    Herzog, Chiara
    Dillner, Joakim
    Widschwendter, Martin
    GENOME MEDICINE, 2022, 14 (01)
  • [50] Serum levels of angiogenin (ANG) in invasive cervical cancer and in cervical intraepithelial neoplasia (CIN)
    Bodner-Adler, B
    Hefler, L
    Bodner, K
    Leodolter, S
    Frischmuth, K
    Kainz, C
    Mayerhofer, K
    ANTICANCER RESEARCH, 2001, 21 (1B) : 809 - 812